Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) CEO Mark L. Baum acquired 9,000 shares of the firm’s stock in a transaction on Friday, March 22nd. The shares were bought at an average cost of $11.59 per share, for a total transaction of $104,310.00. Following the completion of the acquisition, the chief executive officer now […]
Harrow Health, Inc. (NASDAQ:HROW – Get Free Report)’s stock price gapped up before the market opened on Tuesday following insider buying activity. The stock had previously closed at $17.28, but opened at $17.64. Harrow Health shares last traded at $17.73, with a volume of 81,425 shares trading hands. Specifically, CEO Mark L. Baum acquired 5,800 […]
Harrow Health (NASDAQ:HROW – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.01), Briefing.com reports. Harrow Health had a negative return on equity of 1.57% and a negative net margin of 19.76%. The firm had revenue […]
Q2 2023 EPS Estimates for Harrow Health, Inc. Raised by B. Riley (NASDAQ:HROW) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Harrow Health, Inc. (NASDAQ:HROW – Get Rating) was the target of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 2,890,000 shares, an increase of 30.8% from the May 15th total of 2,210,000 shares. Based on an average daily trading volume, of 455,200 shares, […]